| Literature DB >> 25022973 |
Livia Bernardi1, Chiara Cupidi1, Francesca Frangipane1, Maria Anfossi1, Maura Gallo1, Maria Elena Conidi1, Franca Vasso1, Rosanna Colao1, Gianfranco Puccio1, Sabrina A M Curcio1, Maria Mirabelli1, Alessandra Clodomiro1, Raffaele Di Lorenzo1, Nicoletta Smirne1, Raffaele Maletta1, Amalia C Bruni2.
Abstract
Prion protein gene mutations have been associated with clinical pictures mimicking neurodegenerative diseases different from inherited prion diseases (IPD). We report a novel missense P39L mutation in the N-terminal domain of prion protein in 2 patients affected by frontotemporal lobar degeneration syndrome, negative for mutations in genes causative of dementia. Neither the first carrier, a 67-year-old male in which the onset was a progressive non-fluent aphasia, nor the second carrier, a 78-year-old male affected by frontotemporal dementia and parkinsonism, showed any clinical or instrumental findings suggestive of IPD. Genetic screening of healthy controls and in silico analysis provide support for the potential pathogenicity of this variant. Patient phenotypes, unclassifiable as prion disease, may depend on the location of the mutation in the N-terminal domain, outside the amyloid core of pathologic prion protein, although further functional studies are required to determine whether and how this mutation exerts its pathogenic effect. However, genetic screening of prion protein gene becomes relevant in familial degenerative dementia, particularly in geographical areas with high IPD prevalence.Entities:
Keywords: Frontotemporal dementia; N-terminal domain; P39L mutation; Prion protein
Mesh:
Substances:
Year: 2014 PMID: 25022973 DOI: 10.1016/j.neurobiolaging.2014.06.006
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673